D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 55 Citations 17,271 118 World Ranking 10268 National Ranking 368

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Apoptosis
  • Enzyme

Apoptosis, Cell biology, Mitochondrion, Programmed cell death and DNA fragmentation are his primary areas of study. His work on Adenine nucleotide translocator, Reactive oxygen species and Inner mitochondrial membrane as part of his general Cell biology study is frequently connected to DNA damage, thereby bridging the divide between different branches of science. Many of his studies involve connections with topics such as Mitochondrial permeability transition pore and Mitochondrion.

His research in Mitochondrial permeability transition pore intersects with topics in Cyclosporin a, Mitochondrial apoptosis-induced channel and Membrane potential. He has included themes like Ceramide, Fragmentation and Cytolysis in his Programmed cell death study. Philippe Marchetti has researched DNA fragmentation in several fields, including Molecular biology, Semen and Immunology.

His most cited work include:

  • Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. (1403 citations)
  • Mitochondrial control of nuclear apoptosis (1285 citations)
  • Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. (1082 citations)

What are the main themes of his work throughout his whole career to date?

Philippe Marchetti spends much of his time researching Apoptosis, Cell biology, Mitochondrion, Programmed cell death and Cancer research. Philippe Marchetti interconnects Cell, Reactive oxygen species and Immunology in the investigation of issues within Apoptosis. His Adenine nucleotide translocator, Signal transduction and Inner mitochondrial membrane study in the realm of Cell biology interacts with subjects such as DNA damage.

His Mitochondrion research is multidisciplinary, relying on both Lamellarin D, Oxidative phosphorylation, Pharmacology and Mitochondrial permeability transition pore. His study looks at the relationship between Mitochondrial permeability transition pore and topics such as Mitochondrial apoptosis-induced channel, which overlap with Mitochondrial fission and DNAJA3. The concepts of his Programmed cell death study are interwoven with issues in Molecular biology, Ceramide, Fragmentation and Cytolysis.

He most often published in these fields:

  • Apoptosis (42.15%)
  • Cell biology (35.54%)
  • Mitochondrion (33.88%)

What were the highlights of his more recent work (between 2017-2021)?

  • Oxidative phosphorylation (10.74%)
  • Cell biology (35.54%)
  • Cancer research (20.66%)

In recent papers he was focusing on the following fields of study:

Philippe Marchetti mostly deals with Oxidative phosphorylation, Cell biology, Cancer research, Mitochondrion and Cell. His Oxidative phosphorylation study combines topics from a wide range of disciplines, such as Glycolysis, Oxidative stress and Intracellular. His research integrates issues of Cancer and Metabolism in his study of Cell biology.

His studies deal with areas such as Tyrosine kinase and Programmed cell death as well as Cancer research. His Mitochondrion study integrates concerns from other disciplines, such as Muscle tissue and Apoptosis. His Apoptosis research focuses on Toxicity and how it relates to Reactive oxygen species and Inflammation.

Between 2017 and 2021, his most popular works were:

  • Air pollution-derived PM2.5 impairs mitochondrial function in healthy and chronic obstructive pulmonary diseased human bronchial epithelial cells. (46 citations)
  • Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors (35 citations)
  • Melanoma metabolism contributes to the cellular responses to MAPK/ERK pathway inhibitors. (27 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Enzyme
  • Apoptosis

His primary areas of investigation include Mitochondrion, Cell biology, Oxidative phosphorylation, Apoptosis and Melanoma. His study in Mitochondrion is interdisciplinary in nature, drawing from both Muscle tissue and Food science. His work on Cancer expands to the thematically related Cell biology.

His Apoptosis research is multidisciplinary, incorporating elements of Cytokine secretion and Signal transduction. His Melanoma research integrates issues from MEK inhibitor, Programmed cell death, Pentose phosphate pathway and Glutathione. His Programmed cell death research includes elements of Targeted therapy, Intracellular and MAPK/ERK pathway.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.

Naoufal Zamzami;Philippe Marchetti;Maria Castedo;Didier Decaudin.
Journal of Experimental Medicine (1995)

1867 Citations

Mitochondrial control of nuclear apoptosis

Naoufal Zamzami;S. A. Susin;P. Marchetti;T. Hirsch.
Journal of Experimental Medicine (1996)

1798 Citations

Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.

S A Susin;N Zamzami;M Castedo;T Hirsch.
Journal of Experimental Medicine (1996)

1541 Citations

Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.

Naoufal Zamzami;P. Marchetti;M. Castedo;C. Zanin.
Journal of Experimental Medicine (1995)

1481 Citations

Mitochondrial permeability transition is a central coordinating event of apoptosis

Philippe Marchetti;Maria Castedo;Santos A. Susin;Naoufal Zamzami.
Journal of Experimental Medicine (1996)

1093 Citations

Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis

Naoufal Zamzami;Philippe Marchetti;Maria Castedo;Tamara Hirsch.
FEBS Letters (1996)

550 Citations

Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis.

M Castedo;T Hirsch;S A Susin;N Zamzami.
Journal of Immunology (1996)

454 Citations

Study of mitochondrial membrane potential, reactive oxygen species, DNA fragmentation and cell viability by flow cytometry in human sperm

Carole Marchetti;Guillaume Obert;André Deffosez;Pierre Formstecher.
Human Reproduction (2002)

424 Citations

Bcl-2 and Bcl-XL Antagonize the Mitochondrial Dysfunction Preceding Nuclear Apoptosis Induced by Chemotherapeutic Agents

Didier Decaudin;Stephan Geley;Tamara Hirsch;Maria Castedo.
Cancer Research (1997)

416 Citations

Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis.

A Macho;T Hirsch;I Marzo;P Marchetti.
Journal of Immunology (1997)

394 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Philippe Marchetti

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 202

Santos A. Susin

Santos A. Susin

Grenoble Alpes University

Publications: 58

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 51

Paolo Bernardi

Paolo Bernardi

University of Padua

Publications: 50

Boris Zhivotovsky

Boris Zhivotovsky

Karolinska Institute

Publications: 50

Catherine Brenner

Catherine Brenner

Université Paris Cité

Publications: 48

Naoufal Zamzami

Naoufal Zamzami

Centre national de la recherche scientifique, CNRS

Publications: 46

Sten Orrenius

Sten Orrenius

Karolinska Institute

Publications: 34

John J. Lemasters

John J. Lemasters

Medical University of South Carolina

Publications: 33

John C. Reed

John C. Reed

Sanford Burnham Prebys Medical Discovery Institute

Publications: 30

Douglas R. Green

Douglas R. Green

St. Jude Children's Research Hospital

Publications: 30

Oliver Kepp

Oliver Kepp

Institut Gustave Roussy

Publications: 28

Craig B. Thompson

Craig B. Thompson

Memorial Sloan Kettering Cancer Center

Publications: 27

Mark P. Mattson

Mark P. Mattson

Johns Hopkins University School of Medicine

Publications: 26

Klaus-Michael Debatin

Klaus-Michael Debatin

University of Ulm

Publications: 25

Vladimir P. Skulachev

Vladimir P. Skulachev

Lomonosov Moscow State University

Publications: 25

Trending Scientists

Graham Bird

Graham Bird

Claremont Graduate University

Myeong Hee Moon

Myeong Hee Moon

Yonsei University

Luke P. Lee

Luke P. Lee

University of California, Berkeley

Graham Noctor

Graham Noctor

University of Paris-Saclay

Volker Müller

Volker Müller

Goethe University Frankfurt

Guy Cabioch

Guy Cabioch

Institut de Recherche pour le Développement

Joann M. Stock

Joann M. Stock

California Institute of Technology

Christoph Kellendonk

Christoph Kellendonk

Columbia University

Horst-Werner Korf

Horst-Werner Korf

Goethe University Frankfurt

Niels Taatgen

Niels Taatgen

University of Groningen

Peter Brocklehurst

Peter Brocklehurst

University of Birmingham

Akshay S. Desai

Akshay S. Desai

Brigham and Women's Hospital

David B. Dunger

David B. Dunger

University of Cambridge

David N. Herndon

David N. Herndon

The University of Texas Medical Branch at Galveston

Adrian P. Banning

Adrian P. Banning

University of Oxford

Francisco S. N. Lobo

Francisco S. N. Lobo

University of Lisbon

Something went wrong. Please try again later.